The structure of Betamethasone
Find information on thousands of medical conditions and prescription drugs.

Luxiq

Betamethasone is a corticosteroid with anti-inflammatory and immunosuppressive abilities, used especially where water retention is undesirable. It is applied as a topical cream, ointment, lotion or gel to treat itching (e.g. from eczema). more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Indications

Corticosteroid used to stimulate fetal lung maturation and to decrease the incidence and mortality from intracranial hemorrhage in premature infants.

Fetal risk

As it crosses the placenta, which is required for its beneficial effects, it may also be associated with complications, such as hypoglycemia and leucocytosis in newborns exposed in utero.

Read more at Wikipedia.org


[List your site here Free!]


Patients with psoriasis prefer solution and foam vehicles - Washington Whispers - Brief Article
From Journal of Drugs in Dermatology, 4/1/03

The aim of this study was to determine psoriasis patients' preferences for a topical therapy. Focus group sessions were conducted to determine patient perceptions of advantages and disadvantages of different topical therapies currently available for the treatment of psoriasis. Twenty subjects were asked to test and rate 6 different topical corticosteroid vehicles: diflorasone diacetate (Psorcon) emollient, betamethasone valerate (Luxiq) foam, betamethasone diproprionate (Diprolene) ointment and gel, and clobetasol propionate (Cormax) solution and cream. Subjects were asked to assess the effects of the vehicles on quality of life (QOL) and their preference for each vehicle. In addition, patients were asked to score their perception of the importance of thirteen topical treatment characteristics of vehicle application and usage.

Solution and foam preparations were preferred over cream, gel, and ointment preparations (P < .01). There was no difference in vehicle preference during daytime versus nighttime use. Patients reported side effects to be the most important of the 13 topical treatment characteristics assessed for adherence and QOL.

Patient preferences for a particular vehicle may influence adherence and therefore overall efficacy. The findings presented suggest that patient preferences for certain vehicles should be considered when considering which topical product to use in the treatment of psoriasis.

Housman TS, Mellen BG, Rapp SR, Fleischer AB, and Feldman SR. Patients with Psoriasis Prefer Solution and Foam Vehicles: A Quantitative Assessment of Vehicle preference. Cutis 2002 Dec; 70(6):327-332.

COPYRIGHT 2003 Journal of Drugs in Dermatology
COPYRIGHT 2003 Gale Group

Return to Luxiq
Home Contact Resources Exchange Links ebay